Evidence map›Paper›PMID 41918956›Full record

ReviewOpen forum infectious diseases2026

Challenges and Opportunities for Improved Tuberculosis and HIV Prevention in South America.

Cender U Quispe-Juli, Jorge A Gallardo-Cartagena, Larissa Otero, Bruno B Andrade, Julio Croda, Valeria D Cantos, Alberto Mendoza-Ticona, Sandra L Valderrama-Beltrán, Guillermo Sequera, Moises A Huaman

Abstract readReview
In one paragraph

Review in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Cender U Quispe-JuliDoctoral Program in Health Sciences, Faculty of Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru.ORCID https://orcid.org/0000-0003-0633-8339
Jorge A Gallardo-CartagenaCentro de Investigaciones Tecnológicas Biomédicas y Medioambientales, Universidad Nacional Mayor de San Marcos, Lima, Peru.ORCID https://orcid.org/0000-0001-5142-1954
Larissa OteroFacultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID https://orcid.org/0000-0002-8348-4340
Bruno B AndradeOswaldo Cruz Foundation (Fiocruz), Salvador, Brazil.ORCID https://orcid.org/0000-0001-6833-3811
Julio CrodaOswaldo Cruz Foundation (Fiocruz), Salvador, Brazil.ORCID https://orcid.org/0000-0002-6665-6825
Valeria D CantosDivision of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0001-5447-3469
Alberto Mendoza-TiconaSocios en Salud, Lima, Peru.ORCID https://orcid.org/0000-0002-2571-2894
Sandra L Valderrama-BeltránPontificia Universidad Javeriana, Bogotá, Colombia.ORCID https://orcid.org/0000-0003-1833-1599
Guillermo SequeraCátedra de Salud Pública, Facultad de Ciencias Médicas, Universidad Nacional de Asunción, Paraguay.ORCID https://orcid.org/0000-0002-7707-1363
Moises A HuamanDoctoral Program in Health Sciences, Faculty of Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru.ORCID https://orcid.org/0000-0002-6839-5809

Funding

Patient-centered intervention to prevent tuberculosis among children < 5 years oldK43TW011137 · FIC · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI OTERO, LARISSA · 2018 to 2022
$697k
FIC NIH HHS K43 TW011137
6 · The paper itself

Abstract

Tuberculosis (TB) and human immunodeficiency virus (HIV) cause significant morbidity and mortality in South America. Despite the advances in active case finding and early treatment initiation as core strategies to decrease TB and HIV transmissions, additional efforts are needed to achieve control and eventual elimination of these 2 epidemics. Availability and implementation of preventive strategies using shorter, rifamycin-based regimens for TB preventive therapy and long-acting injectables for HIV prevention are still a challenge in the South American region. In this report, we discuss opportunities to accelerate TB and HIV prevention in the region. We present examples of novel TB and HIV surveillance and prevention initiatives among high-risk groups and vulnerable populations in countries within the region, using precision public health approaches and leveraging digital health and artificial intelligence tools. Finally, we propose a roadmap for ending TB and HIV in South America.

Indexed as

HIVpreventionSouth AmericaTuberculosis

Identifiers

PMID41918956
PMCPMC13034732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.